Hepatitis C antiviral treatment in special populations
โ Scribed by Helen S. Yee; Teresa L. Wright
- Book ID
- 107540353
- Publisher
- Current Science Inc.
- Year
- 2003
- Tongue
- English
- Weight
- 341 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed countries. HCV antiviral treatment (peginterferon-a 1 ribavirin) has been shown to be costeffective for patients with no reinfection risk. We examined the cost-effectiveness of providing antiviral treatment
The meta-analysis of propranolol compared with endoscopic variceal ligation for primary prophylaxis of variceal bleeding by Imperiale and Chalasani 1 favors pharmacotherapy despite the fact that "none of the trials measured the hemodynamic response to propranolol." "Blind beta blockade" is the admin